Mathias Zink

6.8k total citations
133 papers, 3.9k citations indexed

About

Mathias Zink is a scholar working on Psychiatry and Mental health, Clinical Psychology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Mathias Zink has authored 133 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 80 papers in Psychiatry and Mental health, 33 papers in Clinical Psychology and 28 papers in Cellular and Molecular Neuroscience. Recurrent topics in Mathias Zink's work include Schizophrenia research and treatment (75 papers), Obsessive-Compulsive Spectrum Disorders (26 papers) and Neuroscience and Neuropharmacology Research (26 papers). Mathias Zink is often cited by papers focused on Schizophrenia research and treatment (75 papers), Obsessive-Compulsive Spectrum Disorders (26 papers) and Neuroscience and Neuropharmacology Research (26 papers). Mathias Zink collaborates with scholars based in Germany, Netherlands and United States. Mathias Zink's co-authors include Susanne Englisch, Frederike Schirmbeck, Fritz A. Henn, Andreas Meyer‐Lindenberg, Franziska Rausch, Andrea Schmitt, Peter J. Gebicke‐Haerter, Christine Esslinger, Sabine Chourbaji and Alexandre Urani and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Neuroscience and SHILAP Revista de lepidopterología.

In The Last Decade

Mathias Zink

129 papers receiving 3.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mathias Zink Germany 33 1.8k 991 840 831 521 133 3.9k
Markus Jäger Germany 37 2.1k 1.2× 1.4k 1.5× 830 1.0× 469 0.6× 490 0.9× 146 4.7k
Stephen Kanes United States 36 1.3k 0.7× 1.2k 1.2× 655 0.8× 1.1k 1.3× 653 1.3× 85 4.6k
Tianmei Si China 34 1.3k 0.7× 1.2k 1.2× 699 0.8× 498 0.6× 471 0.9× 201 3.9k
R.S. Kahn Netherlands 25 1.8k 1.0× 1.4k 1.4× 601 0.7× 1.3k 1.6× 475 0.9× 45 4.0k
Tiago Reis Marques United Kingdom 37 2.2k 1.3× 1.3k 1.3× 693 0.8× 1.1k 1.3× 1.2k 2.3× 112 5.5k
Eckart Rüther Germany 39 1.5k 0.8× 1.0k 1.1× 885 1.1× 590 0.7× 502 1.0× 116 4.8k
William S. Stone United States 40 2.2k 1.3× 2.1k 2.1× 811 1.0× 963 1.2× 391 0.8× 183 5.1k
Ragy R. Girgis United States 38 1.7k 0.9× 1.3k 1.3× 533 0.6× 1.2k 1.4× 632 1.2× 107 4.1k
Tetsuro Ohmori Japan 37 1.3k 0.7× 830 0.8× 495 0.6× 1.3k 1.5× 774 1.5× 180 4.4k
Debra M. Montrose United States 33 1.8k 1.0× 1.4k 1.4× 570 0.7× 442 0.5× 426 0.8× 72 3.3k

Countries citing papers authored by Mathias Zink

Since Specialization
Citations

This map shows the geographic impact of Mathias Zink's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mathias Zink with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mathias Zink more than expected).

Fields of papers citing papers by Mathias Zink

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mathias Zink. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mathias Zink. The network helps show where Mathias Zink may publish in the future.

Co-authorship network of co-authors of Mathias Zink

This figure shows the co-authorship network connecting the top 25 collaborators of Mathias Zink. A scholar is included among the top collaborators of Mathias Zink based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mathias Zink. Mathias Zink is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Müller, Hendrik, Linda T. Betz, Joseph Kambeitz, et al.. (2022). Bridging the phenomenological gap between predictive basic-symptoms and attenuated positive symptoms: a cross-sectional network analysis. Schizophrenia. 8(1). 68–68. 2 indexed citations
2.
Domènech, Cristina, Adriana Pastore, A. Carlo Altamura, et al.. (2019). <p>Correlation of Health-Related Quality of Life in Clinically Stable Outpatients with Schizophrenia</p>. Neuropsychiatric Disease and Treatment. Volume 15. 3475–3486. 11 indexed citations
3.
4.
Haro, Josep María, Carlo Altamura, Ricardo Corral, et al.. (2018). Understanding the course of persistent symptoms in schizophrenia: Longitudinal findings from the pattern study. Psychiatry Research. 267. 56–62. 27 indexed citations
5.
Domènech, Cristina, Carlo Altamura, Corrado Bernasconi, et al.. (2018). Health-related quality of life in outpatients with schizophrenia: factors that determine changes over time. Social Psychiatry and Psychiatric Epidemiology. 53(3). 239–248. 6 indexed citations
6.
Schirmbeck, Frederike, et al.. (2016). Obsessive–compulsive symptoms and overall psychopathology in psychotic disorders: longitudinal assessment of patients and siblings. European Archives of Psychiatry and Clinical Neuroscience. 268(3). 279–289. 16 indexed citations
7.
Schneider, Brooke C., Martin Brüne, Francesca Bohn, et al.. (2016). Investigating the efficacy of an individualized metacognitive therapy program (MCT+) for psychosis: study protocol of a multi-center randomized controlled trial. BMC Psychiatry. 16(1). 51–51. 9 indexed citations
8.
Rietschel, Liz, Martin Lambert, Anne Karow, et al.. (2015). Clinical high risk for psychosis: gender differences in symptoms and social functioning. Early Intervention in Psychiatry. 11(4). 306–313. 52 indexed citations
9.
Schreiner, A., Kaire Aadamsoo, A.C. Altamura, et al.. (2015). Paliperidone palmitate versus oral antipsychotics in recently diagnosed schizophrenia. Schizophrenia Research. 169(1-3). 393–399. 115 indexed citations
10.
Eisenacher, Sarah, Franziska Rausch, Daniela Mier, et al.. (2015). Investigation of metamemory functioning in the at-risk mental state for psychosis. Psychological Medicine. 45(15). 3329–3340. 30 indexed citations
11.
Rausch, Franziska, Sarah Eifler, Christine Esslinger, et al.. (2013). The Early Recognition Inventory ERIraos detects at risk mental states of psychosis with high sensitivity. Comprehensive Psychiatry. 54(7). 1068–1076. 29 indexed citations
12.
Wilmsdorff, Martina von, Mathias Zink, Jens Treutlein, et al.. (2012). Gene expression of glutamate transporters SLC1A1, SLC1A3 and SLC1A6 in the cerebellar subregions of elderly schizophrenia patients and effects of antipsychotic treatment. The World Journal of Biological Psychiatry. 14(7). 490–499. 15 indexed citations
13.
Schirmbeck, Frederike, Franziska Rausch, Susanne Englisch, et al.. (2012). Stable Cognitive Deficits in Schizophrenia Patients With Comorbid Obsessive-Compulsive Symptoms: A 12-Month Longitudinal Study. Schizophrenia Bulletin. 39(6). 1261–1271. 50 indexed citations
14.
Esslinger, Christine, Susanne Englisch, Dragoš Inta, et al.. (2012). Ventral striatal activation during attribution of stimulus saliency and reward anticipation is correlated in unmedicated first episode schizophrenia patients. Schizophrenia Research. 140(1-3). 114–121. 80 indexed citations
15.
Zink, Mathias, Susanne Englisch, & Andreas Meyer‐Lindenberg. (2010). Polypharmacy in schizophrenia. Current Opinion in Psychiatry. 23(2). 103–111. 110 indexed citations
16.
Englisch, Susanne, et al.. (2008). Duloxetine for major depressive episodes in the course of psychotic disorders: an observational clinical trial. Journal of Psychopharmacology. 23(8). 875–882. 17 indexed citations
17.
Zink, Mathias, et al.. (2006). Duloxetine Treatment of Major Depressive Episodes in the Course of Psychotic Disorders. Pharmacopsychiatry. 39(3). 109–111. 2 indexed citations
18.
Ridder, Stephanie, Sabine Chourbaji, Rainer Hellweg, et al.. (2005). Mice with Genetically Altered Glucocorticoid Receptor Expression Show Altered Sensitivity for Stress-Induced Depressive Reactions. Journal of Neuroscience. 25(26). 6243–6250. 327 indexed citations
19.
Zink, Mathias & Rainer Spanagel. (2005). Ethanol induces GAD67 and VGAT in slice cultures of newborn rat cerebral cortex. Neuroreport. 16(4). 377–380. 5 indexed citations
20.
Zink, Mathias, Alexander Sartorius, & Florian Lederbogen. (2004). Remission of polydipsia as antipsychotic effect of clozapine. European Psychiatry. 19(5). 320–321. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Markus Jäger Breakdown of academic impact, for papers by Stephen Kanes Breakdown of academic impact, for papers by Tianmei Si Breakdown of academic impact, for papers by R.S. Kahn Breakdown of academic impact, for papers by Tiago Reis Marques Breakdown of academic impact, for papers by Eckart Rüther Breakdown of academic impact, for papers by William S. Stone Breakdown of academic impact, for papers by Ragy R. Girgis Breakdown of academic impact, for papers by Tetsuro Ohmori Breakdown of academic impact, for papers by Debra M. Montrose
Rankless by CCL
2026